Literature DB >> 22895183

MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2.

Chunmei Piao1, Cha-Kyung Youn, Min Jin, Sang Pil Yoon, In-Youb Chang, Jung Hee Lee, Ho Jin You.   

Abstract

The p53R2 protein, a newly identified member of the ribonucleotide reductase family that provides nucleotides for DNA damage repair, is directly regulated by p53. We show that p53R2 is also regulated by a MEK2 (ERK kinase 2/MAP kinase kinase 2)-dependent pathway. Increased MEK1/2 phosphorylation by serum stimulation coincided with an increase in the RNR activity in U2OS and H1299 cells. The inhibition of MEK2 activity, either by treatment with a MEK inhibitor or by transfection with MEK2 siRNA, dramatically decreased the serum-stimulated RNR activity. Moreover, p53R2 siRNA, but not R2 siRNA, significantly inhibits serum-stimulated RNR activity, indicating that p53R2 is specifically regulated by a MEK2-dependent pathway. Co-immunoprecipitation analyses revealed that the MEK2 segment comprising amino acids 65-171 is critical for p53R2-MEK2 interaction, and the binding domain of MEK2 is required for MEK2-mediated increased RNR activity. Phosphorylation of MEK1/2 was greatly augmented by ionizing radiation, and RNR activity was concurrently increased. Ionizing radiation-induced RNR activity was markedly attenuated by transfection of MEK2 or p53R2 siRNA, but not R2 siRNA. These data show that MEK2 is an endogenous regulator of p53R2 and suggest that MEK2 may associate with p53R2 and upregulate its activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895183      PMCID: PMC3466523          DOI: 10.4161/cc.21591

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.

Authors:  L Fang; G Li; G Liu; S W Lee; S A Aaronson
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

2.  p53 sends nucleotides to repair DNA.

Authors:  G Lozano; S J Elledge
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

3.  p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.

Authors:  T Yamaguchi; K Matsuda; Y Sagiya; M Iwadate; M A Fujino; Y Nakamura; H Arakawa
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

4.  Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.

Authors:  Linda S Steelman; Patrick Navolanic; William H Chappell; Stephen L Abrams; Ellis W T Wong; Alberto M Martelli; Lucio Cocco; Franca Stivala; Massimo Libra; Ferdinando Nicoletti; Lyudmyla B Drobot; Richard A Franklin; James A McCubrey
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

5.  Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo.

Authors:  M Fukushima; A Fujioka; J Uchida; F Nakagawa; T Takechi
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

6.  A ribonucleotide reductase gene is a transcriptional target of p53 and p73.

Authors:  K Nakano; E Bálint; M Ashcroft; K H Vousden
Journal:  Oncogene       Date:  2000-08-31       Impact factor: 9.867

7.  Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53.

Authors:  S W Lee; L Fang; M Igarashi; T Ouchi; K P Lu; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest.

Authors:  X Wang; C H McGowan; M Zhao; L He; J S Downey; C Fearns; Y Wang; S Huang; J Han
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.

Authors:  O Guittet; P Håkansson; N Voevodskaya; S Fridd; A Gräslund; H Arakawa; Y Nakamura; L Thelander
Journal:  J Biol Chem       Date:  2001-08-21       Impact factor: 5.157

10.  Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.

Authors:  W Cui; E M Yazlovitskaya; M S Mayo; J C Pelling; D L Persons
Journal:  Mol Carcinog       Date:  2000-12       Impact factor: 4.784

View more
  6 in total

1.  Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration.

Authors:  Chunmei Piao; Lun Cai; Shulan Qiu; Lixin Jia; Wenchao Song; Jie Du
Journal:  J Biol Chem       Date:  2015-03-04       Impact factor: 5.157

2.  Clb6-Cdc28 Promotes Ribonucleotide Reductase Subcellular Redistribution during S Phase.

Authors:  Xiaorong Wu; Xiuxiang An; Caiguo Zhang; Mingxia Huang
Journal:  Mol Cell Biol       Date:  2018-02-27       Impact factor: 4.272

3.  Checkpoint-dependent RNR induction promotes fork restart after replicative stress.

Authors:  Esther C Morafraile; John F X Diffley; José Antonio Tercero; Mónica Segurado
Journal:  Sci Rep       Date:  2015-01-20       Impact factor: 4.379

4.  RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy.

Authors:  Waleed Iqbal; Elena V Demidova; Samantha Serrao; Taha ValizadehAslani; Gail Rosen; Sanjeevani Arora
Journal:  Front Genet       Date:  2021-03-12       Impact factor: 4.599

5.  PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.

Authors:  Mei-Ling Kuo; Mabel Bin-Er Lee; Michelle Tang; Willem den Besten; Shuya Hu; Michael J Sweredoski; Sonja Hess; Chih-Ming Chou; Chun A Changou; Mingming Su; Wei Jia; Leila Su; Yun Yen
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

Review 6.  [Ribonucleotide reductase and non-small cell lung cancer].

Authors:  Nan-Yung Hsu; Hue Lee; Ya-Wen Cheng; Yun Yen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.